The mechanism by which HSD alleviated AD symptoms may be achieved by inhibiting of the mTOR/HIF-1α signaling pathway, modulating BV2 glycolytic reprogramming, and attenuating neuroinflammation. This evidence concerns the gene HIF1A and Alzheimer disease.